Evidence map›Paper›PMID 29532631›Full record

ArticleDiabetes, obesity & metabolism2018

Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission.

Laurentiu M Pop, Andrea Mari, Tong-Jin Zhao, Lori Mitchell, Shawn Burgess, Xilong Li, Beverley Adams-Huet, Ildiko Lingvay

Abstract readComparative Study
In one paragraph

Article in Diabetes, obesity & metabolism, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Bariatric Surgery in NAFLD.Digestive diseases and sciences · 2022
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Laurentiu M PopDepartment of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
Andrea MariNational Research Council, Institute of Neuroscience, Padua, Italy.
Tong-Jin ZhaoDepartment of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, Texas.
Lori MitchellDepartment of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.
Shawn BurgessAdvanced Imaging Research Center, University of Texas Southwestern Medical Center, Dallas, Texas.
Xilong LiDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Beverley Adams-HuetDepartment of Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, Texas.
Ildiko LingvayDepartment of Internal Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Texas Southwestern Medical Center, Dallas, Texas.ORCID 0000-0001-7006-7401
The University of Texas Southwestern Medical Center · USNeuroscience Institute · ITSouthwestern Medical Center · USThe University of Texas Medical Branch at Galveston · USXiamen University · CN

Funding

NORTH AND CENTRAL TEXAS CTSA FOR PEDIATRIC RESEARCHUL1RR024982 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2007 to 2011
$27.9M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
North and Central Texas Clinical and Translational Science Initiative (KL2)KL2RR024983 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2007 to 2011
$4.3M
UT Southwestern Center for Translational Medicine (UL1/KL2/TL1KL2TR001103 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$4.0M
Role of Pancreatic Triglycerides in Beta-cell DysfunctionK23RR024470 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI LINGVAY, ILDIKO · 2007 to 2011
$755k
NCATS NIH HHS KL2 TR001103NCATS NIH HHS UL1 TR001105NCRR NIH HHS K23 RR024470NCRR NIH HHS KL2 RR024983NCRR NIH HHS UL1 RR024982
6 · The paper itself

Abstract

aimsTo investigate the physiological mechanisms leading to rapid improvement in diabetes after Roux-en-Y gastric bypass (RYGB) and specifically the contribution of the concurrent peri-operative dietary restrictions, which may also alter glucose metabolism. MATERIALS AND

methodsIn order to assess the differential contributions of diet and surgery to the mechanisms leading to the rapid improvement in diabetes after RYGB we enrolled 10 patients with type 2 diabetes scheduled to undergo RYGB. All patients underwent a 10-day inpatient supervised dietary intervention equivalent to the peri-operative diet (diet-only period), followed by, after a re-equilibration (washout) period, an identical period of pair-matched diet in conjunction with RYGB (diet and RYGB period). We conducted extensive metabolic assessments during a 6-hour mixed-meal challenge test, with stable isotope glucose tracer infusion performed before and after each intervention.

resultsSimilar improvements in glucose levels, β-cell function, insulin sensitivity and post-meal hepatic insulin resistance were observed with both interventions. Both interventions led to significant reductions in fasting and postprandial acyl ghrelin. The diet-only intervention induced greater improvements in basal hepatic glucose output and post-meal gastric inhibitory polypeptide (GIP) secretion. The diet and RYGB intervention induced significantly greater increases in post-meal glucagon-like peptide-1 (GLP-1), peptide YY (PYY) and glucagon levels.

conclusionsStrict peri-operative dietary restriction is a main contributor to the rapid improvement in glucose metabolism after RYGB. The RYGB-induced changes in the incretin hormones GLP-1 and PYY probably play a major role in long-term compliance with such major dietary restrictions through central and peripheral mechanisms.

Indexed as

Caloric RestrictionGastric BypassInsulin ResistanceBlood GlucoseDiabetes Mellitus, Type 2FastingFemaleGastric Inhibitory PolypeptideGhrelinGlucagonGlucagon-Like Peptide 1HumansInsulin-Secreting CellsInsulin SecretionLiverMaleBlood GlucoseGastric Inhibitory PolypeptideGhrelinGlucagonGlucagon-Like Peptide 1Peptide YYdiabetes remissiondiet restrictiongastric bypass surgeryglycaemic control

Identifiers

PMID29532631
PMCPMC5999551
OpenAlexW2808216448

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.